Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.855
+0.055 (1.96%)
Nov 21, 2024, 1:19 PM EST - Market open
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for AUTL stock have an average target of 10.2, with a low estimate of 7.60 and a high estimate of 13. The average target predicts an increase of 257.27% from the current stock price of 2.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AUTL stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $7 → $7.6 | Hold → Strong Buy | Upgrades | $7 → $7.6 | +166.20% | Nov 18, 2024 |
| Redburn Atlantic | Redburn Atlantic | Hold → Strong Buy Upgrades $13 | Hold → Strong Buy | Upgrades | $13 | +355.34% | Nov 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +250.26% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +250.26% | Nov 12, 2024 |
| Needham | Needham | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +215.24% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
15.57M
from 1.70M
Increased by 816.67%
Revenue Next Year
73.85M
from 15.57M
Increased by 374.47%
EPS This Year
-0.84
from -1.20
EPS Next Year
-0.69
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 52.5M | 171.7M | 188.5M | ||
| Avg | 15.6M | 73.9M | 155.8M | ||
| Low | 9.8M | 20.8M | 125.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2,991.9% | 1,003.3% | 155.2% | ||
| Avg | 816.7% | 374.5% | 110.9% | ||
| Low | 477.1% | 33.5% | 70.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.70 | -0.21 | -0.18 | ||
| Avg | -0.84 | -0.69 | -0.52 | ||
| Low | -0.90 | -0.91 | -0.89 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.